THE MORPHINE ABSTINENCE SYNDROME, ITS NATURE AND TREATMENT

Article1 November 1941THE MORPHINE ABSTINENCE SYNDROME, ITS NATURE AND TREATMENTC. K. HIMMELSBACH, M.D.C. K. HIMMELSBACH, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-15-5-829 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDrug addiction is a condition in which an individual has become sufficiently subject to an effect of a drug that he can no longer exert adequate self-control with regard to its continued use. Consequently, a separation of the patient from the drug is essential to successful treatment for drug addiction, no matter whether it has been established to opiates, marijuana, barbiturates, alcohol, tobacco, caffeine, or to any other drug or combination. The various drug addictions differ from one another in the manner and extent to which they confer tolerance, habituation, and physical dependence. Tolerance is the term used to denote...References1. JEWETT SP: Cocain addiction, Tice, Practice of Med., 1935, viii, 53-55. Google Scholar2. DREISBACH RH: Experimental caffeine withdrawal headache, Proc. Am. Soc. Pharm. and Exper. Therap., 1940, lxix, 283. Google Scholar3. ANDREWS HL: Some effects of morphine and morphine addiction on the human electroencephalogram (in press). Google Scholar4. WILLIAMS EG: Blood concentration in morphine addicts, Jr. Pharm. and Exper. Therap., 1939, lxvii, 290. Google Scholar5. MORAT D: Le sang et les sécrétions au corus de la morphinomanie et de la desintoxication, 1911, Thèse de Paris. Google Scholar6. ROWNTREE LG: The effects on mammals of the administration of excessive quantities of water, Jr. Pharm. and Exper. Therap., 1926, xxix, 135. Google Scholar7. GRINKERSEROTA RRH: Studies on corticohypothalamic relations in the cat and man, Jr. Neurophysiol., 1938, i, 573-589. CrossrefGoogle Scholar8. KOLBHIMMELSBACH LCK: Clinical studies of drug addiction. III. A critical review of withdrawal treatments with method of evaluating abstinence syndromes, Am. Jr. Psychiat., 1938, xciv, 759. CrossrefGoogle Scholar9. Report of the Mayor's Committee on Drug Addiction, Am. Jr. Psychiat., 1930, x, 433. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: United States Public Health Service United States Public Health Service Hospital Lexington, Kentucky*Received for publication October 30, 1940.Presented at the Southern Psychiatric Assoc., Jacksonville, Florida, October 22, 1940.The term "morphine" as used throughout this paper includes the phenanthrene derivatives of opium used in the practice of medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byNeurochemical Mobile: A Heuristic Tool for Understanding Dynamic Complexity and Treatment of Alcohol WithdrawalProperties of the Problematic Pornography Consumption Scale (PPCS-18) in community and subclinical samples in China and HungaryRole of Hippocampal Neurogenesis in Alcohol Withdrawal SeizuresThe recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorderSlow‐sustained delivery of naloxone reduces typical naloxone‐induced precipitated opioid withdrawal effects in male morphine‐dependent miceOpioid use disorderThe past, present and future of opioid withdrawal assessment: a scoping review of scales and technologiesL'analgésie n'est pas simple silenceTakotsubo Cardiomyopathy precipitated by opiate withdrawalIatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and ManagementOpioid-Induced Hyperalgesia Syndrome in the Rehabilitation PatientComing Off DrugsRisky Bodies, Drugs and BiopoliticsTolerance and withdrawal symptoms may not be helpful to enhance understanding of behavioural addictionsContributions to drug abuse research of Steven R. Goldberg's behavioral analysis of stimulus-stimulus contingenciesIntranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusersEfficacy and safety of naloxegol in patients with opioid‐induced constipation and laxative‐inadequate responseA Case Report of Acute Esotropia in a Young Woman following Heroin WithdrawalRandomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipationNaloxegol for Opioid-Induced Constipation in Patients with Noncancer PainA Double Blind, within Subject Comparison of Spontaneous Opioid Withdrawal from Buprenorphine versus MorphineThe Genetics of Alcohol Responses of Invertebrate Model SystemsPerspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and AlcoholismAlcohol-Induced Histone Acetylation Reveals a Gene Network Involved in Alcohol ToleranceA DNA Element Regulates Drug Tolerance and Withdrawal in DrosophilaOpiate Substitution Treatment: Poisoned Bodies and the History of SubstitutionIs alcoholism learned? Insights from the fruit flyMethadone at tapered doses for the management of opioid withdrawalThe history of the development of buprenorphine as an addiction therapeuticThe Impact of Changes in Neuroscience and Research Ethics on the Intellectual History of Addiction ResearchMethylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness: A 3-Month Open-Label Treatment Extension StudyHomeostatic Cont of Neural Activity: A Drosophila Model for Drug Tolerance and DependenceTolerance to allopregnanolone with focus on the GABA-A receptorThe role of adverse events and related safety data in the pre-market evaluation of drug abuse potentialModeling withdrawal syndrome in zebrafishImagery Scripts and a Computerized Subtraction Stress Task Both Induce Stress in Methamphetamine Users: A Controlled Laboratory StudyConcurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrumentOverview on Clinical Features of Opioid-Induced HyperalgesiaEffectiveness of two opioid antagonistsin treating opioid-induced constipationBrief buprenorphine detoxification for the treatment of prescription opioid dependence: A pilot studyAlvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer painOpioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluationSubcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging StudyPupillometry and Eye Tracking as Predictive Measures of Drug AbuseEvaluation of a transdermal buprenorphine formulation in opioid detoxificationLes opioïdesInvestigating the pharmacological and nonpharmacological factors that modulate drug reinforcement.Pharmacodynamics"A new deal for the drug addict": The Addiction Research Center, Lexington, KentuckyA sensitization–homeostasis model of nicotine craving, withdrawal, and tolerance: Integrating the clinical and basic science literatureEvaluation of an injection depot formulation of buprenorphine: placebo comparisonEffects of a High-Dose, Fast Tapering Buprenorphine Detoxification Program on Symptom Relief and Treatment RetentionMeasuring the emergence of tobacco dependence: the contribution of negative reinforcement modelsOpioidsOpen-label trial of an injection depot formulation of buprenorphine in opioid detoxificationThe Clinical Opiate Withdrawal Scale (COWS)Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humansPhysiological and behavioral effects of acute ethanol hangover in juvenile, adolescent, and adult rats.Heroin withdrawal as a possible cause of acute concomitant esotropia in adultsChapter 8 Ibogaine in the treatment of heroin withdrawalOral naloxone reverses opioid-associated constipationNaloxone-Precipitated Acute Opioid Withdrawal Syndrome After Epidural MorphineLong‐lasting increased pain sensitivity in rat following exposure to heroin for the first timeHypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: A case of naloxone-induced withdrawalPatient Perceptions of Psychological and Physiological Withdrawal Symptoms and Positive Factors Associated with Gradual Withdrawal from Methadone Maintenance Treatment: A Prospective StudyMecamylamine does not precipitate withdrawal in cigarette smokersBiological factorsLong-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid AgonistsSubjective and objective symptoms in relation to plasma methadone concentration in methadone patientsAcute physical dependence: Time course and relation to human plasma morphine concentrations*Current concepts of ethanol dependenceOverview: Biological processes relevant to drugs of dependenceAn open trial of low dose buprenorphine in treating methadone withdrawalOpioid physical dependence development in humans: effect of time between agonist pretreatmentsCocaine: Diagnosis and TreatmentThe Dysphoria of Heroin AddictionAcute opioid physical dependence in humans: Effect of naloxone at 6 and 24 hours postmorphineA portable pupilometer system for measuring pupillary size and light reflexAssessment of Opioid Dependence with NaloxoneAddiction Research Center Inventory (ARCI): Measurement of Euphoria and Other Drug EffectsTwo New Rating Scales for Opiate WithdrawalPatient perspectives of opiate withdrawalNEUROENDOCRINE CHANGES DURING MENOPAUSAL FLUSHESOPIATE WITHDRAWAL SYNDROME: ACUTE AND PROTRACTED ASPECTSTreatment of narcotic addiction by inhibition of craving: Contending with a cherished habitOpiates: Human PsychopharmacologyBarbiturate Withdrawal Syndrome in CatsWithdrawal characteristics following chronic pentobarbital dosing in catDescriptive Study of Behavior during Transition from Heroin Addict to Methadone PatientHuman sleep and EEG through a cycle of methadone dependenceThe Management of Drug Abuse in Aging Populations: New Orleans FindingsSubjective Experiences Produced by the Withdrawal of OpiatesThe narcotic addict as a medical patientThe Experimental Production of Narcotic Drug Effects and Withdrawal Symptoms Through HypnosisObstetric and gynecologic aspects of heroin addictionTreatment of drug addiction 1 November 1941Volume 15, Issue 5Page: 829-839KeywordsAlcoholsCaffeineDrug addictionDrugsMarijuanaMorphineOpiatesOpium Issue Published: 1 November 1941 PDF downloadLoading ...